Potentiation of anticoagulants.

Suppr

超能文献

作者信息

Hoffbrand B I, Kininmonth D A

出版信息

Br Med J. 1967 Jun 24;2(5555):838-9. doi: 10.1136/bmj.2.5555.838-b.

DOI:10.1136/bmj.2.5555.838-b

PMID:6029151

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1843101/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa7f/1843101/71efe2ddea91/brmedj02141-0089-a.jpg

相似文献

Potentiation of anticoagulants.

Br Med J. 1967 Jun 24;2(5555):838-9. doi: 10.1136/bmj.2.5555.838-b.

Potentiation of anticoagulant effect of warfarin by phenylbutazone.保泰松对华法林抗凝作用的增强作用。

N Engl J Med. 1967 Mar 2;276(9):496-501. doi: 10.1056/NEJM196703022760904.

[Interaction between anticoagulants and indomethacin].

Tidsskr Nor Laegeforen. 1974 Nov 30;94(33):2313-4.

Pharmacokinetic analysis of potentiating effect of phenylbutazone on anticoagulant action of warfarin in man.保泰松对人华法林抗凝作用增强效应的药代动力学分析。

J Pharm Sci. 1970 Sep;59(9):1258-61. doi: 10.1002/jps.2600590909.

Comparison of feprazone and phenylbutazone interaction with warfarin in man.非普拉宗与保泰松与人华法林相互作用的比较。

Curr Ther Res Clin Exp. 1975 Oct;18(4):568-72.

Warfarin-phenylbutazone interaction in man: a long term multiple dose study.华法林与保泰松在人体中的相互作用：一项长期多剂量研究。

Res Commun Chem Pathol Pharmacol. 1975 Apr;10(4):663-72.

Comparative pharmacokinetics of coumarin anticoagulants XLV: Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin and phenylbutazone in rats.

J Pharm Sci. 1980 Jan;69(1):14-20. doi: 10.1002/jps.2600690105.

Letter: Drug enhancement of warfarin activity.

Lancet. 1975 Sep 20;2(7934):557-8. doi: 10.1016/s0140-6736(75)90937-x.

Competition between diftalone and other drugs for the binding site(s) on human serum albumin.双他氯铵与其他药物在人血清白蛋白上结合位点的竞争。

Med Biol. 1976 Jun;54(3):187-92.

Hyaluronate synthesis by human synovial cells in monolayer culture under treatment with indomethacin and phenylbutazone.

Pharmacology. 1971;5(2):97-102. doi: 10.1159/000136180.

引用本文的文献

Drug interactions.

Calif Med. 1969 Feb;110(2):175.

Adverse interaction between warfarin and indomethacin.华法林与吲哚美辛之间的不良相互作用。

Drug Saf. 1994 Mar;10(3):267-9. doi: 10.2165/00002018-199410030-00006.

Adverse interaction between warfarin and indomethacin.

Drug Saf. 1994 Sep;11(3):213-4. doi: 10.2165/00002018-199411030-00006.

Combining NSAIDs with anticoagulants: yes and no.非甾体抗炎药与抗凝剂联用：可行与不可行。

Can Med Assoc J. 1984 Oct 15;131(8):857-9.

The clinician's approach to drug interactions.临床医生应对药物相互作用的方法。

Calif Med. 1968 Nov;109(5):380-9.

Plasma protein binding of dipyrone metabolites in man.人身上安乃近代谢物的血浆蛋白结合情况。

Eur J Clin Pharmacol. 1985;29(1):67-71. doi: 10.1007/BF00547371.

[Pharmaco-kinetic aspects of protein-binding (author's transl)].蛋白质结合的药代动力学方面（作者译）

Klin Wochenschr. 1978 Dec 15;56(24):1195-204. doi: 10.1007/BF01477075.

本文引用的文献

[Vascular allergid due to butalidon and hazards of its combined used with athrombon (phenylindandione)].[布他利酮引起的血管过敏及其与抗凝血剂（苯茚二酮）联合使用的风险]

Dermatol Wochenschr. 1961 Feb 18;143:172-8.

[Increase of anticoagulant activity with butazolidin].[保泰松对抗凝活性的增强作用]

Schweiz Med Wochenschr. 1956 Oct 20;86(42):1194-5.

Potentiation of anticoagulant effect of warfarin by phenylbutazone.保泰松对华法林抗凝作用的增强作用。

N Engl J Med. 1967 Mar 2;276(9):496-501. doi: 10.1056/NEJM196703022760904.

Potentiation of anticoagulant therapy by oxyphenylbutazone. (A probable case).羟苯基丁唑酮增强抗凝治疗作用（疑似病例）。

Postgrad Med J. 1965 Sep;41(479):563-5. doi: 10.1136/pgmj.41.479.563.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验